RxDoctor Payments Data

Amanda Edmond, PA

Physician Assistant · Gilbert, AZNPI 1770767683

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 88.9% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $30,918, more than ten times the $342 reported in 2022. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,012in general payments, 2019–2025

Across 86 payments — averaging $372.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$28K
  • Merck$1K
  • Bayer$814
  • GRT US Holding, Inc.$311
  • AbbVie$175
  • Amgen$150
  • plus $821 from 13 others

What the payments were for

  • Consulting fees$9,24529%
  • Speaking & faculty fees$13,43042%
  • Travel & lodging$6,41620%
  • Food & beverage$2,7439%
  • Education$1781%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,012 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$52,405
Medicare patients
199
Services billed
537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$25,566
Prochlorperazine Maleate28$796
Potassium Chloride36$597
Gabapentin47$571
Ondansetron Hcl53$525
Dexamethasone35$482
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine22$479
Albuterol Sulfate HfaAlbuterol Sulfate15$478
Triamcinolone Acetonide48$403
Levofloxacin18$383
Lidocaine Hcl ViscousLidocaine Hcl20$380
Clindamycin Phosphate13$295
Omeprazole11$276
Ondansetron OdtOndansetron11$249
Prednisone95$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$25,56631 claims
Lilly USA, LLCOlanzapine$16$10212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →